Ontario Deprescribing Project Update - July 2014
|
|
- Kenneth Walters
- 5 years ago
- Views:
Transcription
1 Subscribe Share Past Issues Translate Ontario Deprescribing Project Update - July 2014 View this in your browser Ontario Deprescribing Project Update July 2014 The evidence based Deprescribing guidelines aim to support interdisciplinary teams of healthcare professionals in tapering or stopping medications and monitoring for adverse drug withdrawal reactions in elderly patients. The project s research team expects that this will reduce adverse drug effects, polypharmacy, and improve quality of life. News Proton Pump Inhibitor Deprescribing Guideline (Guideline #1) Proton Pump Inhibitor (PPI): A class of medications/drugs that reduce acid production in your stomach. They are commonly used to treat heartburn, among other conditions. First deprescribing guideline team has finished its draft guideline; clinical review is complete. Implementation of the PPI Deprescribing Guideline has started at 6 sites in the Ottawa area. Some of our sites include: Long-Term Care Facilities Hillel Lodge Perley and Rideau Veteran s Health Centre St. Patrick's Home of Ottawa Family Health Teams Bruyère Academic Family Health Team Rideau Family Health Team Benzodiazepine Deprescribing Guideline (Guideline #2) Benzodiazepine: A class of medications/drugs also called hypnotics or sedatives that are commonly used for insomnia, among other conditions.
2 Welcome to Benzodiazepine Deprescribing Guideline Development team members: Dr. Kevin Pottie, MD, Clinical Scientist, C.T. Lamont Centre, Bruyère Research Institute (Guideline Lead) Dr. Cynthia Boyd, MD, Associate Professor, Center on Aging and Health, School of Public Health, Johns Hopkins University Dr. Simon Davies, MBBS, Assistant Professor, Department of Psychiatry, University of Toronto Dr. Barbara Farrell, PharmD, Clinical Scientist, C.T. Lamont Centre, Bruyère Research Institute Dr. Anne Holbrook, MD, Professor, Division of Clinical Pharmacology and Therapeutics, Department of Medicine, McMaster University Dr. Cheryl Sadowski, PharmD, Associate Professor, Faculty of Pharmacy & Pharmaceutical Sciences, University of Alberta Dr. Robert Swenson, MD, Professor, Department of Psychiatry, Faculty of Medicine, University of Ottawa Dr. Vivian Welch, PhD, Clinical Epidemiology Methodologist, Bruyère Research Institute The team met on June 26, 2014 to establish the scope and parameters for development of the Benzodiazepine Deprescribing Guideline. We anticipate the guideline will be ready for clinical review this Fall. Spreading the Word The Center of Research Excellence at The University of Queensland Australia hosted its first National Workshop on Deprescribing on May 20, Our project s Principal Investigor, Barbara Farrell, presented to an international audience via Skype on the topic of making deprescribing part of routine care. Participants showed great interest and expressed their appreciation on social media. PPI Deprescribing Guideline Development team members Kate Walsh and Barbara Farrell facilitated a 45 minute workshop for over 100 Canadian Pharmacists Association members at their annual meeting in Saskatoon, SK. on June 2, Participants provided excellent feedback about the guideline and associated tools which were incorporated prior to pilot site implementation in later June. About 20 people attended a session on the Deprescribing project at the 2014 Canadian Evaluation Conference in Ottawa on June 17. James Conklin, co-principal Investigator on the project, explained how developmental evaluation is being used to gather and analyze qualitative data about the deprescribing team s process, and to help the team strengthen its capacity to develop and implement deprescribing guidelines. The session was followed by a lively discussion, suggesting that the deprescribing project is of interest to both clinicians and evaluators. The Deprescribing Team plans to disseminate the unique methods of the Deprescribing project to North American audiences this fall with abstract submissions to: AGM of the Regional Geriatric Program of Eastern Ontario, October 2014 (Ottawa, ON) Annual Meeting of the North American Primary Care Research Group, November 2014 (New York, NY) On is excited to have over 600 followers! Have you deprescribed a medication, managed a patient with polypharmacy, used an effective nonpharmacological intervention? Have you had a personal experience with reducing or stopping medication? Tweet us your deprescribing stories. What do you want to know more about? Tweet us with
3 your questions or comments! Spotlight on Deprescribing Clinical Tips for Deprescribing As people age, cardiovascular medications, including antihypertensive therapies, should be regularly reviewed when assessing common geriatric presentations such as falls, dizziness and hypotension. (1) The differential diagnosis of any sign or symptom should always include the question, Could this be caused by a drug? (1) Drugs with anticholinergic properties can have additive effects, with the result being a high anticholinergic load. (2) Use the Beers or STOPP (Screening Tool of Older Persons potentially inappropriate Prescriptions) screening criteria to identify potentially inappropriate medications for the elderly. (3) Useful links Sources Articles on anticholinergic load Tune LE. Anticholinergic effects of medication in elderly patients. J Clin Psychiatry 2001;62(Suppl 21):11-4. Ancelin ML, Artero S, Portet F, et al. Non-degenerative mild cognitive impairment in elderly people and use of anticholinergic drugs: longitudinal cohort study. BMJ 2006;332: Rudolph JL, Salow MJ, Angelini MC, et al. The anticholinergic risk scale and anticholinergic adverse effects in older persons. Arch Intern Med 2008;168: Mintzer J, Burns A. Anticholinergic side-effects of drugs in elderly people. J R Soc Med 2000;93: Carrière I, Fourrier-Reglat A, Dartigues JF, et al. Drugs with anticholinergic properties, cognitive decline, and dementia in an elderly general population: the 3-city study. Arch Intern Med 2009; 169: Pasina L, Djade CD, Lucca U, et al. Association of anticholinergic burden with cognitive and functional status in a cohort of hospitalized elderly: comparison of the anticholinergic cognitive burden scale and anticholinergic risk scale: results from the REPOSI Study. Drugs Aging 2013;30: Shi X, Wray DW, Formes KJ, et al. Orthostatic hypotension in aging humans. Am J Physiol Heart Circ Physiol 2000;279: H BEERS Criteria: STOPP Criteria: biomedcentral.com 1. Reducing fall risk while managing pain and insomnia: Addressing polypharmacy in an 81-year-old woman. Canadian Pharmacists Journal : CPJ = Revue Des Pharmaciens Du Canada : RPC 2013;146(6): Managing polypharmacy in a 77-year-old woman with multiple prescribers. CMAJ : Canadian Medical Association Journal = Journal De l'association Medicale Canadienne, 2013;185(14): Identifying and managing drug-related causes of common geriatric symptoms. Canadian Family Physician Medecin De Famille Canadien, 2014;60(2): International Progress The Australian Deprescribing Network (ADeN) consists of clinicians and researchers with an active interest in
4 deprescribing and comprises geriatricians, general physicians, general practitioners, clinical pharmacists, clinical epidemiologists and a health economist. It features representation from tertiary and primary care, quality use of medicine agencies, including the National Prescribing Service (Australia), and guideline developers. The Network was established at a workshop held in Brisbane on May 20, 2014 and it seeks to lessen the iatrogenic drug burden in older patients on a national scale. For more information on ADeN, contact Dr. Ian Scott, Director of Internal Medicine and Clinical Epidemiology, Queensland University, at ian.scott@health.qld.gov.au. Emily Reeve (School of Pharmacy and Medical Sciences at the University of South Australia) and her team recently published a paper on deprescribing in the March 2014 edition of the British Journal of Pharmacology Reeve, E., Shakib, S., Hendrix, I., Roberts, M. S., & Wiese, M. D. (2014). Review of deprescribing processes and development of an evidence based, patient-centred deprescribing process. British Journal of Clinical Pharmacology (2014) doi: /bcp Fun Facts While not yet incorporated into an official English dictionary, the term deprescribing is catching on. Deprescribing produces 8,000 search results in Google; Prescribing produces 31 million. More work is needed! Deprescribing Team Update Congratulations to Hannah Irving, our Deprescribing Project Manager, who gave birth to a beautiful baby girl, Fiona, on June 3, During her maternity leave, Lisa Pizzola will take over the role of Project Manager, bringing with her the experience gained in coordinating development of the PPI Deprescribing Guideline. We are pleased to welcome Lindsay Anderson, Hillary Bernosky, David de Launay, and Khaled Eid to our summer team! Hillary & Khaled are second year pharmacy students at the University of Waterloo. Lindsay is a second year medical student at the University of Ottawa, and David is a BSc (Psychology) student at the University of Ottawa. Read more about their backgrounds at Keep in Touch Follow us on Contact us: deprescribing@bruyere.org Check us out online: Contribute to our Wikipedia page: search deprescribing To subscribe or unsubscribe to the list, please deprescribing@bruyere.org
5 Copyright 2014 Bruyere Research Insitute, All rights reserved. Graphic Credits: "Newspaper" designed by John Caserta from The Noun Project "Announcement" designed by Oliviera Guin from The Noun Project "Clipboard" designed by Scott Lewis from The Noun Project "Conversation" designed by Marcio Duarte from The Noun Project
Using Deprescribing Guidelines in Long-Term Care: The Ottawa Experience
Using Deprescribing Guidelines in Long-Term Care: The Ottawa Experience Barbara Farrell, BScPhm, Pharm D, FCSHP James Conklin, PhD Bruyère Research Institute, Ottawa Co-authors: Hannah Irving, Lalitha
More informationDisclosure. The elderly at risk: reducing medications safely to meet life s changes. Relevant financial relationships.
The elderly at risk: reducing medications safely to meet life s changes Barbara Farrell BScPhm, PharmD, FCSHP European Society of Hospital Pharmacists Conference March 2017 Disclosure Relevant financial
More informationOutcome Statement: National Stakeholders Meeting on Quality Use of Medicines to Optimise Ageing in Older Australians
Outcome Statement: National Stakeholders Meeting on Quality Use of Medicines to Optimise Ageing in Older Australians Executive summary Australia has a significant opportunity to improve the quality use
More informationDavid Gardner, BSc Pharm, MSc CH&E, PharmD Professor, Department of Psychiatry & College of Pharmacy
David Gardner, BSc Pharm, MSc CH&E, PharmD Professor, Department of Psychiatry & College of Pharmacy It s no dream. Sleep well without sleeping pills. Outline Baby boomers & beyond: medication use Deprescribing
More informationAbout ISMP Canada. Analysis Outputs: Safety Bulletins. Less is More: An Introduction to Deprescribing. canada.org
Less is More: An Introduction to Deprescribing Lindsay Yoo, BSc, BScPhm, RPh, CDE, CGP, PharmD Medication Safety Analyst, ISMP Canada About ISMP Canada The Institute for Safe Medication Practices Canada
More informationLess is More: Introduction to Deprescribing
Less is More: Introduction to Deprescribing 7th Annual Pharmaceutical Care Conference Muscat, Oman Feb 23, 2017 Lindsay Yoo, BSc, BScPhm, RPh, CDE, CGP, PharmD Medication Safety Analyst, ISMP Canada About
More informationShared decision making for stepdown and stopping decisions. Michael R. Gionfriddo Pharm.D, Ph.D Geisinger Center for Pharmacy Innovation and Outcomes
Shared decision making for stepdown and stopping decisions Michael R. Gionfriddo Pharm.D, Ph.D Geisinger Center for Pharmacy Innovation and Outcomes 1 Disclosures I have had travel and lodging paid for
More informationOpioid de-prescribing guidelines?
Opioid de-prescribing guidelines? Feng Chang, RPh, BScPhm, PharmD Associate Professor University of Waterloo, School of Pharmacy Waterloo, Canada #derx2018 Outline Introduction De-prescribing guideline
More informationEvidence-Based Clinical Practice Guideline for Deprescribing Cholinesterase Inhibitors and Memantine in People with Dementia
Evidence-Based Clinical Practice Guideline for Deprescribing Cholinesterase Inhibitors and Memantine in People with Dementia ADI 2018, Chicago FACULTY OF MEDICINE Dr Emily Reeve NHMRC Cognitive Decline
More informationTransforming Care for the Elderly
Transforming Care for the Elderly Session 2: Engaging Pharmacists & Interdisciplinary Care Teams to Improve Prescribing of Antipsychotics & to Reduce Polypharmacy January 11, 2017 3 @cfhi_fcass Welcome
More informationEvidence-based Clinical Practice Guideline for Deprescribing Cholinesterase Inhibitors and Memantine
Evidence-based Clinical Practice Guideline for Deprescribing Cholinesterase Inhibitors and Memantine Developing organisations: The University of Sydney NHMRC Partnership Centre: Dealing with Cognitive
More informationGRADE, EBM and Deprescribing. Kevin Pottie MD CCFP, MClSc, FCFP Associate Professor, Family Medicine, University of Ottawa
GRADE, EBM and Deprescribing Kevin Pottie MD CCFP, MClSc, FCFP Associate Professor, Family Medicine, University of Ottawa Research is like turning on the light before you clean up the room: it doesn t
More informationReduction of High Risk Medications Using A Quality Initiative Perspective
Reduction of High Risk Medications Using A Quality Initiative Perspective Richard Mueller PharmD, MBA, MS, Director of Pharmacy Dianne Hempel BSN, RN Quality Improvement Coordinator Objectives Learn what
More informationCanadian Deprescribing Network
Canadian Deprescribing Network 2017 Annual Report 1 What s deprescribing? Deprescribing is the planned and supervised process of reducing or stopping medications that may no longer be of benefit or may
More informationPRESCRIBING FOR PEOPLE WITH DEMENTIA; SELECTED FINDINGS FROM POMH-UK QUALITY IMPROVEMENT PROGRAMMES (QIPS)
PRESCRIBING FOR PEOPLE WITH DEMENTIA; SELECTED FINDINGS FROM POMH-UK QUALITY IMPROVEMENT PROGRAMMES (QIPS) The Prescribing Observatory for Mental Health (POMH-UK) is a national initiative to improve the
More informationPreventing Medication Related Falls
A Team Approach to Deprescribing and Preventing Medication Related Falls Wednesday, February 13 th 2019 Pam Howell THIS WEBINAR IS BEING RECORDED. THE SLIDE DECK AND RECORDING WILL BE EMAILED AFTER THE
More informationOptimizing medication in caring for seniors living with frailty: Five perspectives
Optimizing medication in caring for seniors living with frailty: Five perspectives Community Care Shanna Trenaman BScH, BScPharm, MAHSR, ACPR, PhD(student) Project Manager for A Collaborative Intervention
More informationDeprescribing Unnecessary Medications: A Four-Part Process
Deprescribing Unnecessary Medications: A Four-Part Process Scott Endsley, MD Fam Pract Manag. 2018;25(3):28-32. Abstract and Introduction Introduction www.medscape.com Ms. Horatio is a 76-year-old patient
More informationNBPDP Drug Utilization Review Process Update
Bulletin # 802 December 1, 2010 NBPDP Drug Utilization Review Process Update The New Brunswick Prescription Drug Program (NBPDP) employs a Drug Utilization Review (DUR) process which identifies, investigates
More informationOptimising Safe & Appropriate Medicines Use and Deprescribing. Katie Smith, Director, East Anglia Medicines Information Service February 2014
Optimising Safe & Appropriate Medicines Use and Deprescribing Katie Smith, Director, East Anglia Medicines Information Service February 2014 Background Objectives How & why the OSAMU document was developed
More informationTITLE: Discontinuation of Benzodiazepines and Other Sedative-Hypnotic Sleep Medication in Hospitalized Patients: Clinical Evidence and Guidelines
TITLE: Discontinuation of Benzodiazepines and Other Sedative-Hypnotic Sleep Medication in Hospitalized Patients: Clinical Evidence and Guidelines DATE: 25 September 2015 RESEARCH QUESTIONS 1. What is the
More informationConflict of interest declaration and sources of funding
Potentially Inappropriate Prescribing immediately prior to Long-Term Care admission (PIP in LTC): Validation of tools for their future use across Ontario Bruyère CLRI Webinar March 24 th, 2016 and Bruyère
More informationPolypharmacy. in the Elderly. Lesley Charles, MBChB, CCFP
Polypharmacy in the Elderly Lesley Charles, MBChB, CCFP Associate Professor and Program Director Division of Care of the Elderly Department of Family Medicine, University of Alberta March 06, 2016 1 Faculty/Presenter
More informationPolypharmacy and Deprescribing for Older People
Polypharmacy and Deprescribing for Older People Sarah Hilmer Head of Department, Clinical Pharmacology and Senior Staff Specialist Aged Care, RNSH Conjoint Professor of Geriatric Pharmacology, Sydney University
More informationPharmaceutical Society of Singapore Pharmacy Week Polypharmacy in Singapore: The Role of Deprescribing
Pharmaceutical Society of Singapore Pharmacy Week 2015 Polypharmacy in Singapore: The Role of Deprescribing Introduction In Singapore, life expectancy has continually increased due to greater accessibility
More informationMedicines in Older People- Some of the Key Issues
Medicines in Older People- Some of the Key Issues Associate Professor Vasi Naganathan Sydney Medical School Consultant Geriatrician, Centre for Education and Research on Ageing Concord Hospital, Sydney,
More informationFirst do no harm? The importance of communicating overdiagnosis in guideline recommendations:
First do no harm? The importance of communicating overdiagnosis in guideline recommendations: Approach of the Canadian Task Force on Preventive Health Care Wilson BJ, Bell NR, Grad R, Groulx S, Moore A,
More informationKatee Kindler, PharmD, BCACP
Speaker Introduction Katee Kindler, PharmD, BCACP Current Practice: Clinical Pharmacy Specialist Ambulatory Care, St. Vincent Indianapolis Assistant Professor of Pharmacy Practice, Manchester University,
More informationOptimizing the function of elderly patients is critical for them to live in their homes for as long as possible. Elderly
Turning over the rocks Role of anticholinergics and benzodiazepines in cognitive decline and falls Barbara Farrell PharmD FCSHP Pamela Eisener-Parsche MD CCFP FCFP CCPE Dan Dalton RPh Optimizing the function
More informationDeprescribing antipsychotics for behavioural and psychological symptoms of dementia and insomnia
CLINICAL PRACTICE GUIDELINES Deprescribing antipsychotics for behavioural and psychological symptoms of dementia and insomnia Evidence-based clinical practice guideline Lise M. Bjerre MD PhD CCFP Barbara
More informationPOLYPHARMACY. A practical approach to deprescribing in care homes. Care Home Pharmacy Team. Herts Valleys Clinical Commissioning Group
POLYPHARMACY A practical approach to deprescribing in care homes. Care Home Pharmacy Team Herts Valleys Clinical Commissioning Group Neeta Gulhane Specialist Pharmaceutical Advisor Care Homes The Care
More informationPolypharmacy. A CPPE distance learning programme
A CPPE distance learning programme DLP 177 January 2016 Contents About CPPE distance learning programmes About this learning programme Glossary of key terms v vii ix Contents Section 1 The problem with
More informationIan Scott. Director of Internal Medicine and Clinical Epidemiology Princess Alexandra Hospital
National Workshop in Deprescribing Setting the scene Ian Scott Director of Internal Medicine and Clinical Epidemiology Princess Alexandra Hospital Associate Professor of Medicine University of Queensland
More informationIMPROVING MEDICATION SAFETY AMONG ELDERLY PATIENTS IN AN AMBULATORY SETTING. Alyssa Berry, Rebecca Burgett, Erin Day, Aron Hrubetz
IMPROVING MEDICATION SAFETY AMONG ELDERLY PATIENTS IN AN AMBULATORY SETTING Alyssa Berry, Rebecca Burgett, Erin Day, Aron Hrubetz Improving Medication Safety Among Elderly Patients in an Ambulatory Setting
More informationSponsorship Prospectus
Sponsorship Prospectus Supporting Health System Transformation April 14 to 16, Edmonton We are pleased to invite you to partner with CADTH for our 15th annual Symposium and the celebration of our 30th
More informationPolypharmacy and Polymorbid Patients: Practical Tips and Tricks
Polypharmacy and Polymorbid Patients: Practical Tips and Tricks November 2, 2013 Faculty/Presenter Disclosure Faculty: Chris Fan-Lun, BScPhm, ACPR, CGP Pharmacist - Geriatric Medicine Clinical Practice
More informationMedication Use in Older Adults
Medication Use in Older Adults F. Michael Gloth, III, MD, AGSF, FACP, CMD Clinical Professor Department of Geriatrics, Florida State University College of Medicine Associate Professor of Medicine Division
More informationSupplemental materials for:
Supplemental materials for: Wallis KA, Andrews A, Henderson M. Swimming against the tide: primary care physicians views on deprescribing in everyday practice. Ann Fam Med. 2017;15(4):341-346. General Practice
More informationAround fifteen semi-structured interviews are going to be conducted with specialist physicians of the domains selected for the checklist.
1 SEMI-STRUCTURED INTERVIEW GUIDE THE INTERVIEW PROCESS This interview is intended to create statements of potential interest for a prescription-screening checklist to detect potentially inappropriate
More informationMichelle Greiver Simone Dahrouge Patricia O Brien Donna Manca Marie-Thérèse Lussier
Michelle Greiver Simone Dahrouge Patricia O Brien Donna Manca Marie-Thérèse Lussier University of Toronto Practice Based Research Network Ottawa Practice Enhancement Network Quality & Innovation Program,
More informationThank You to Our Sponsors: Evaluations & CE Credits. Featured Speakers. Conflict of Interest & Disclosure Statements 10/18/2016
Thank You to Our Sponsors: University at Albany School of Public Health NYS Department of Health Conflict of Interest & Disclosure Statements The planners and presenters do not have any financial arrangements
More informationQUALITY USE OF MEDICINES TO OPTIMISE AGEING IN OLDER AUSTRALIANS:
QUALITY USE OF MEDICINES TO OPTIMISE AGEING IN OLDER AUSTRALIANS: Recommendations for a National Strategic Action Plan to Reduce Inappropriate Polypharmacy Suggested citation: Quality Use of Medicines
More informationDeconstructing Polypharmacy. Alan B. Douglass, M.D. Director
Deconstructing Polypharmacy Alan B. Douglass, M.D. Director Recognize this patient? Mrs. Brown- 82 years young Active Medical Problems Hypertension Hyperlipidemia Type 2 Diabetes Peripheral edema Osteoarthritis
More informationTargeted Deprescribing in Patients on Hemodialysis to Decrease Polypharmacy
Targeted Deprescribing in Patients on Hemodialysis to Decrease Polypharmacy Presentation Objectives Discuss Polypharmacy In HD patients Define Deprescribing Review results of the pilot study on deprescribing
More informationThe Ontario Medical Association and the Champlain LHIN. Caring for the Elderly in Champlain: The Primary Care Perspective. Friday, January 13, 2012
The Ontario Medical Association and the Champlain LHIN Presents Caring for the Elderly in Champlain: The Primary Care Perspective Friday, January 13, 2012 Location: The Hampton Inn Ottawa and Conference
More informationDoreen Wan-Chow-Wah, MD, FRCPC Assistant Professor, Division of Geriatric Medicine, Department of Medicine McGill University Health Center Associate
Doreen Wan-Chow-Wah, MD, FRCPC Assistant Professor, Division of Geriatric Medicine, Department of Medicine McGill University Health Center Associate member, Department of Oncology McGill University Medical
More information2018 THERAPEUTICS UPDATE
The Canadian Society of Pharmacology and Therapeutics 2018 THERAPEUTICS UPDATE Course Overview This one-day course on May 22, 2018 will explore emerging areas of interest in drug therapy and drug safety.
More informationTELUS Health Conference Toronto
TELUS Health Conference Toronto Dr. Wendy Levinson, MD, OC Chair, Choosing Wisely Canada & International Professor of Medicine, University of Toronto March 23rd, 2016 Wedges of Waste 2 I ve always done
More informationApplication for Endorsement of CQI (Clinical Audit) Activities for MOPS Credits Allocation
Application for Endorsement of CQI (Clinical Audit) Activities for MOPS Credits Allocation Below is the form you need to fill out. NAME Dianne Vicary Health Hawke s Bay DATE JUNE 2012 TITLE OF ACTIVITY
More informationAkinbolade O, Husband A, Forrest S, Todd A. Deprescribing in advanced illness. Progress in Palliative Care 2016, 24(5),
Akinbolade O, Husband A, Forrest S, Todd A. Deprescribing in advanced illness. Progress in Palliative Care 2016, 24(5), 268-271 Copyright: This is an Accepted Manuscript of an article published by Taylor
More informationCASA PRESENTS: THE DR. ROGER BLAND LECTURE SERIES ON CHILDREN S MENTAL HEALTH
CASA PRESENTS: THE DR. ROGER BLAND LECTURE SERIES ON CHILDREN S MENTAL HEALTH A partnership between CASA Child, Adolescent and Family Mental Health, the University of Alberta, the Institute of Health Economics,
More informationDeprescribing proton pump inhibitors
Clinical Practice Guidelines Deprescribing proton pump inhibitors Evidence-based clinical practice guideline Barbara Farrell PharmD ACPR FCSHP Kevin Pottie MD CCFP MClSc FCFP Wade Thompson Taline Boghossian
More informationViolence against Women: Health and Justice for Canadian Muslim Women Project Overview
Violence against Women: Health and Justice for Canadian Muslim Women Project Overview 1 Project s Terms of Reference Project Overview Funded by the Status of Women Canada, this two year project (October
More informationMedications are Additive (Anticholinergic) Diane W. Healey, M.D. Center for Healthy Aging March 10, 2017
Medications are Additive (Anticholinergic) Diane W. Healey, M.D. Center for Healthy Aging March 10, 2017 Disclosures This speaker has indicated there are no relevant financial relationships to be disclosed.
More informationPharmacology in the Elderly
Pharmacology in the Elderly James Hardy Geriatrician, Royal North Shore Hospital A recent consultation Aspirin Clopidogrel Warfarin Coloxyl with senna Clearlax Methotrexate Paracetamol Pantoprazole Cholecalciferol
More informationSTAKEHOLDER CONSULTATION
STAKEHOLDER CONSULTATION DRAFT NSW CANNABIS MEDICINES PRESCRIBING GUIDANCE BACKGROUND Many Australians are now able to access cannabinoids for medicinal purposes under the supervision of a medical practitioner.
More informationNewsletter July Building an Integrated Regional SGS Program. Behaviour Supports Ontario Funding. Clinical Design Implementation
Newsletter July 2018 Building an Integrated Regional SGS Program Clinical Design Implementation In early 2018, the NSM SGS program hired health care consultant Carol Anderson, a previous vice president
More informationREGISTER TO ATTEND THIS FREE EVENT. brisbane diamantina health partners
BDHP Brain and Mental Health Conference Translational research in Neuroscience: Bridging the gap between basic science and clinical practice Tuesday 28 August 2018 Bancroft Auditorium QIMR Berghofer Medical
More informationCOMMON DRUG RELATED PROBLEMS SEEN IN PACE AND MECHANISMS TO MITIGATE RISK
COMMON DRUG RELATED PROBLEMS SEEN IN PACE AND MECHANISMS TO MITIGATE RISK Robert L Alesiani, PharmD, CGP Chief Pharmacotherapy Officer CareKinesis, Inc. (a Tabula Rasa Healthcare Company) 2 3 4 5 Pharmacogenomics
More informationDRUG UTILIZATION STUDIES TO GUIDE BETTER HOSPITAL PHARMACEUTICAL POLICY
DRUG UTILIZATION STUDIES TO GUIDE BETTER HOSPITAL PHARMACEUTICAL POLICY Dr. G. Parthasarathi Professor, Pharmacy Practice JSS University, Mysore 30 October 2011 ACPE6 Beijing, 2011 1 Presentation Outline
More informationDeprescribing benzodiazepine receptor agonists
Deprescribing benzodiazepine receptor agonists Evidence-based clinical practice guideline CLINICAL PRACICE GUIDELINES Kevin Pottie MD MClSc CCFP FCFP Wade hompson RPh MSc Simon Davies DM MB BS MSc Jean
More informationPotentially Inappropriate Medications in Elderly Patients: Prevalence at Admission and Changes During Hospital Stay
Potentially Inappropriate Medications in Elderly Patients: Prevalence at Admission and Changes During Hospital Stay Background Polypharmacy in the Elderly 40% seniors are using 5-9 different classes of
More informationSubmission on the Draft National Clinical Practice Guidelines for Dementia in Australia
Submission on the Draft National Clinical Practice Guidelines for Dementia in Australia 4 June 2015 details Name of organisation Royal Australian College of General Practitioners () Postal Address Legal
More informationCanadian HIV/AIDS Pharmacists Network. Association Canadienne des Pharmaciens en VIH/SIDA. Terms of Reference
Canadian HIV/AIDS Pharmacists Network Association Canadienne des Pharmaciens en VIH/SIDA Terms of Reference Revised 11 May 2016 Canadian HIV/AIDS Pharmacists Network Association Canadienne des Pharmaciens
More informationImproving the quality of care for people with dementia and their carers
NHMRC Partnership Centre Dealing with Cognitive and Related Functional Decline in Older People (Cognitive Decline Partnership Centre) Improving the quality of care for people with dementia and their carers
More informationEvolve Better care. Better decision-making. Better use of resources.
Evolve Better care. Better decision-making. Better use of resources. Dr Sarah Hilmer BScMed(Hons) MBBS(Hons) FRACP PhD Professor of Geriatric Pharmacology Sydney Medical School The University of Sydney
More informationChanging patterns of sedative use over time in older adults in Ontario
Changing patterns of sedative use over time in older adults in Ontario Andrea Iaboni, MD, DPhil, FRCPC Toronto Rehabilitation Institute University Health Network Faculty/Presenter Disclosure Faculty: Andrea
More informationPOLICY FRAMEWORK FOR DENTAL HYGIENE EDUCATION IN CANADA The Canadian Dental Hygienists Association
POLICY FRAMEWORK FOR DENTAL HYGIENE EDUCATION IN CANADA 2005 The Canadian Dental Hygienists Association October, 2000 Replaces January, 1998 POLICY FRAMEWORK FOR DENTAL HYGIENE EDUCATION IN CANADA, 2005
More informationThe STOPP/START Criteria: International Synthesis and Local Contextualization
The STOPP/START Criteria: International Synthesis and Local Contextualization Presented November 21, 2014 to TVN MindMerge TVN Improving care for the frail elderly Barbara Hill-Taylor IMPART, College of
More informationWebinar Series April 11, 2018
Webinar Series April 11, 2018 Reducing post-discharge potentially inappropriate medications amongst the elderly: a multi-centre electronic deprescribing intervention Todd Lee, MD, MPH, FRCPC McGill University
More informationProgress from the Patient-Centered Outcomes Research Institute (PCORI)
Progress from the Patient-Centered Outcomes Research Institute (PCORI) Anne Beal, Chief Operating Officer of the Patient-Centered Outcomes Research Institute Sharon-Lise Normand, Vice Chair, Methodology
More information4/26/2016 DISCLOSURES BACKGROUND OBJECTIVES BACKGROUND BACKGROUND
http://thinkprogress.org/health/01/10//1061/how-rising-health-care-costs-impact-the-national-budget/ http://www.firstaidforfree.com/wp-content/uploads/015/09/falls.jpg http://drwills.com/wp-content/uploads/015/05/drugcycle.jpg
More informationA n n u a l Report 2016/2017
Annual Report 2016/2017 Kathy Wright Award winner for exemplary care in Geriatrics 2016 GERIATRIC ASSESSMENT OUTREACH TEAM (GAOT): BUILDING GERIATRIC SYSTEM CAPACITY The Geriatric Assessment Outreach Team
More informationSTART, STOPP, Beers Oh My! Navigating the World of Geriatric Pharmacy
START, STOPP, Beers Oh My! Navigating the World of Geriatric Pharmacy Jessica DiLeo, PharmD Kate Murphy, PharmD OBJECTIVES Identify pharmacodynamic and pharmacokinetic parameters that may influence treatment
More informationThe principles that guide optimal prescribing
CMAJ CME Deprescribing for older patients Christopher Frank MD, Erica Weir MD MSc See related editorial at www.cmaj.ca/lookup/doi:10.1503/cmaj.122099 and articles at www.cmaj.ca/lookup/doi:10.1503/cmaj.122012
More informationThe 16th Annual Geriatric Services Conference DRAFT PROGRAM
GERIATRIC SERVICES CONFERENCE The 16th Annual Geriatric Services Conference DRAFT PROGRAM CONNECT. COLLABORATE. CREATE. Friday, April 12, 2019 Vancouver Convention Centre The 16th Annual Geriatric Services
More informationDecreasing the Harms from Prescription Drug Misuse: A Case for Pharmacists and Prescription Monitoring Programs
Decreasing the Harms from Prescription Drug Misuse: A Case for Pharmacists and Prescription Monitoring Programs Beth Sproule, BScPhm, PharmD Clinician Scientist Centre for Addiction and Mental Health &
More informationUpdate in Geriatrics: Choosing Wisely Primum Non Nocere
Joseph G. Ouslander, M.D. Professor of Clinical Biomedical Science Senior Associate Dean for Geriatric Programs Chair, Department of Integrated Medical Science Charles E. Schmidt College of Medicine Professor
More informationThere s A Pill For That (But should my patient be on it?) A Review of Tools for the Evaluation of Optimal Prescribing in Geriatric Patients
There s A Pill For That (But should my patient be on it?) A Review of Tools for the Evaluation of Optimal Prescribing in Geriatric Patients Marilyn N. Bulloch, PharmD, BCPS Assistant Clinical Professor
More informationThe 16th Annual Geriatric Services Conference DRAFT PROGRAM
GERIATRIC SERVICES CONFERENCE The 16th Annual Geriatric Services Conference DRAFT PROGRAM CONNECT. COLLABORATE. CREATE. Friday, April 12, 2019 Vancouver Convention Centre The 16th Annual Geriatric Services
More informationMedication safety in vulnerable patient groups - Elderly patients -
Woodennature/CC-BY-SA-3.0 http://theintelligence.de Medication safety in vulnerable patient groups - Elderly patients - 20th Congress of EAHP 25-27 March, 2015, Hamburg, Germany Dr. rer. nat. Beate Wickop
More informationAN INTEGRATED APPROACH TO BENZODIAZEPINE DISCONTINUATION: SHARED MEDICAL APPOINTMENTS FOR VETERANS CO-PRESCRIBED OPIOIDS AND BENZODIAZEPINES
AN INTEGRATED APPROACH TO BENZODIAZEPINE DISCONTINUATION: SHARED MEDICAL APPOINTMENTS FOR VETERANS CO-PRESCRIBED OPIOIDS AND BENZODIAZEPINES Elizabeth (Betsy) Crowe, PhD Lucille J. Carriere, PhD Objectives
More informationDr. Michel Joffres Dr. Gabriela Lewin Dr. Patricia Parkin Dr. Kevin Pottie (telecon) Dr. Elizabeth Shaw Dr. Harminder Singh
Last Edited by Diane Perazzo 28/05/13 CANADIAN TASK FORCE ON PREVENTIVE HEALTH CARE February 11 12, 2013 Meeting PUBLIC RECORD OF MEETING (REVISED: MAY 28, 2013) Present: CTFPHC Members Chair: Dr. Marcello
More informationTable of Contents Interim Report of the OxyContin Task Force, Newfoundland & Labrador, January 30, 2004
OXYCONTIN TASK FORCE INTERIM REPORT January 30, 2004 Submitted to Hon. Elizabeth Marshall, Minister of Health & Community Services, Government of Newfoundland and Labrador Table of Contents INTRODUCTION
More informationDeprescribing: A Practical Guide
Deprescribing: A Practical Guide The information in this booklet should be used as a pragmatic decision aid, in conjunction with other relevant patient specific data. Useful resource links http://www.derbyshiremedicinesmanagement.nhs.uk/assets/clinical_guidelines/clinical_guidelines_fr
More informationPatient-Centred Research Priorities Relating to Healthcare of Frail Older Canadians
Patient-Centred Research Priorities Relating to Healthcare of Frail Older Canadians Canadian Frailty Network Annual National Conference April 24, 2017 Jennifer Bethell, Martine Puts, Katherine McGilton,
More informationFalls Assessment and Medication
Falls Assessment and Medication Professor T.Masud President-Elect British Geriatrics Society Nottingham University Hospitals NHS Trust, UK Visiting Professor University of Southern Denmark Mrs GH is a
More informationNutrition Education in the PharmD Curriculum at the University of Waterloo School of Pharmacy. Cynthia Richard, BScPh, PhD Paul Spagnuolo, PhD
Nutrition Education in the PharmD Curriculum at the University of Waterloo School of Pharmacy Cynthia Richard, BScPh, PhD Paul Spagnuolo, PhD Outline Overview of UW pharmacy curriculum Pharmacists knowledge
More informationCONTRACTING ORGANIZATION: Mount Sinai School of Medicine, New York, NY 10029
AD Award Number: W81XWH-11-1-0604 TITLE: An Intervention to Control Vasomotor Symptoms for Advanced PC Patients on Hormone Therapy PRINCIPAL INVESTIGATOR: Michael A. Diefenbach, Ph.D. CONTRACTING ORGANIZATION:
More informationCOMPUS OPTIMAL THERAPY REPORT. Supporting Informed Decisions. À l appui des décisions éclairées. Proton Pump Inhibitor Project Overview: Summaries
OPTIMAL THERAPY REPORT COMPUS Volume 1, Issue 1 March 2007 Proton Pump Inhibitor Project Overview: Summaries Supporting Informed Decisions À l appui des décisions éclairées This Executive Summary is based
More informationCLINICAL CLERKSHIP IN GERIATRIC MEDICINE ORIENTATION PACKAGE (updated July 2007)
CLINICAL CLERKSHIP IN GERIATRIC MEDICINE ORIENTATION PACKAGE (updated July 2007) This package is an abbreviated version of essential information for the geriatrics rotation. Please review the Geriatrics
More informationThe 16th Annual Geriatric Services Conference PROGRAM
GERIATRIC SERVICES CONFERENCE The 16th Annual Geriatric Services Conference PROGRAM CONNECT. COLLABORATE. CREATE. Friday, April 12, 2019 Vancouver Convention Centre The 16th Annual Geriatric Services Conference
More informationIf a bad thing is happening to a patient, a drug did it until proven otherwise
Dr Vicki s First Rule of Geriatrics Deprescribing in the Elderly Victoria Braund MD, FACP, CMD Director, Division of Geriatrics NorthShore University HealthSystem Medical Director, Brandel Health & Rehab
More informationDocument Title Pharmacological Management of Generalised Anxiety Disorder
Document Title Pharmacological Management of Generalised Anxiety Disorder Document Description Document Type Policy Service Application Trust Wide Version 1.1 Policy Reference no. POL 201 Lead Author(s)
More informationMeds and Falls: Keep in Step with your Meds
Meds and Falls: Keep in Step with your Meds Donna Bartlett PharmD, CGP, RPh Associate Professor-Pharmacy Practice MCPHS University Clinical Pharmacist-MCPHS University- Pharmacy Outreach Program donna.bartlett@mcphs.edu
More informationUse of anti-psychotic medication in care homes Response from the Royal Pharmaceutical Society in Wales
Use of anti-psychotic medication in care homes Response from the Royal Pharmaceutical Society in Wales About us The Royal Pharmaceutical Society (RPS) is the professional body for pharmacists in Great
More informationSALTY Improving End of Life Care in Long Term Care Janice Keefe Scientific Lead and Co Lead Stream 4
SALTY Improving End of Life Care in Long Term Care Janice Keefe Scientific Lead and Co Lead Stream 4 Matthais Hobin PDF and Co-lead Stream 1 SENIORS- ADDING LIFE TO YEARS (SALTY) Funding Partners Canadian
More informationManagement of the Frail Older Patients: What Are the Outcomes
Management of the Frail Older Patients: What Are the Outcomes Professor Edwina Brown Imperial College Renal and Transplant Centre Hammersmith Hospital, London Increasing prevalence of old old on RRT RRT
More informationPolymedication in nursing home. Graziano Onder Centro Medicina dell Invecchiamento Università Cattolica del Sacro Cuore Rome - Italy
Polymedication in nursing home Graziano Onder Centro Medicina dell Invecchiamento Università Cattolica del Sacro Cuore Rome - Italy Services and Health for Elderly in Long TERm care (SHELTER) 4156 residents
More informationCommunity Pharmacy-Based A1c Screening A Canadian Model for Diabetes Care
Community Pharmacy-Based A1c Screening A Canadian Model for Diabetes Care Welcome We will begin shortly. Please ensure your computer speakers are turned on. Pharmacy Research Webinar Series Hosted by:
More information